Antibiotic Class Details
Linezolid is a synthetic oxazolidinone, representing the first member of this entirely new class of antibacterial agents to reach the market in over 35 years, approved in 2000. 2, 3
Mechanism of Action
- Inhibits bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S ribosomal subunit 1, 2
- Prevents formation of the functional 70S initiation complex, which is essential for bacterial translation 2
- This mechanism of action is unique to the oxazolidinone class, making cross-resistance with other antibiotic classes unlikely 2, 4
Antimicrobial Activity
- Bacteriostatic against enterococci and staphylococci 2
- Bactericidal against most streptococci strains 2
- Active against aerobic Gram-positive bacteria, with clinical utility particularly against drug-resistant organisms 2, 4
Clinical Significance
The oxazolidinone class represents a novel mechanism distinct from all other antibacterial agents, which is why linezolid maintains activity against vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA). 1, 3 This unique binding site at the 50S ribosomal subunit differentiates it from beta-lactams, glycopeptides, macrolides, and all other established antibiotic classes. 2, 5